Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Assessment of thrombotic risk and pathophysiological mechanisms of splenectomy-associated hypercoagulability in patients with immune thrombocytopenia

View Full Paper
Ask AI
Bookmark
Share

Authors

FOFernanda Andrade Orsi

Discussion

Loading...

Member takes

Overview

Retrospective cohort study reveals higher thrombotic risk and von Willebrand factor levels in splenectomized patients with immune thrombocytopenia.

Key Points

  • Thrombotic risk is significantly higher in splenectomized patients compared to non-splenectomized individuals.
  • The study found a 12% thrombosis rate in splenectomized patients vs. 3% in non-splenectomized ones, indicating increased risk.
  • Retrospective analysis highlighted the association of splenectomy with higher factor VIII and von Willebrand factor levels.
  • Findings suggest that persistent hypercoagulable states may lead to thrombotic events long after splenectomy.

Cite This Study

Fernanda Andrade Orsi (2025) studied this question.

synapsesocial.com/papers/69362f7f4fa91c937236e55ehttps://doi.org/10.1182/blood-2025-3029
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Is splenectomy one of the contributory factors to pulmonary hypertension? An analysis of splenectomized hemolytic anemia and immune thrombocytopenia patients2025
  2. 2Beyond Platelet Counts: Assessing Safety of Post-Splenectomy TPO-RA Use in ITP2025
  3. 3Outcomes of splenectomy in benign and malignant hematologic conditions in the immunotherapy era2025
  4. 4In-hospital stroke, myocardial infarction, and venous thrombosis in immune thrombocytopenia: Incidence, risk factors, and outcomes from a national cohort2025
  5. 5Geographic and diagnostic variations in thrombosis risk among patients with immune thrombocytopenia: A systematic review and meta-analysis2025